🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Status
Unknown
Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Start Date
2014-12
Trial ID
NCT02794337
This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Status
Unknown
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2019-09-15
Trial ID
NCT04143191
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
Transarterial chemoembolization (TACE) is considered the gold standard for ...
Status
Terminated
Location
Cancer Center Sun Yat-sen University
Start Date
2014-12
Trial ID
NCT02220088
Treatments Being Tested
The purpose of this study is to determine the feasibility to combine sorafe...
Status
Completed
Location
Inselspital
Start Date
2007-05
Trial ID
NCT00478374
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of hepatic...
Status
Completed
Location
Dongguan People's Hospital
Start Date
2016-08
Trial ID
NCT02856126
The study will be a single-center, randomized Phase II study of conventiona...
Status
Withdrawn
Location
Smilow Cancer Center
Start Date
2016-06
Trial ID
NCT02908165
The purpose of this study is to evaluate the safety and efficacy of the com...
Status
Unknown
Location
Kinki University Hospital
Start Date
2010-10
Trial ID
NCT01217034
Treatments Being Tested
To determine the maximum tolerated radiation dose with concurrent sorafenib...
Status
Withdrawn
Location
Froedtert Memorial Lutheran Hospital
Start Date
2012-06
Trial ID
NCT01618253
Treatments Being Tested
Toripalimab is a programmed cell death protein 1 antibody.This is an open-l...
Status
Unknown
Location
Zhongshan Hospital
Start Date
2019-08-01
Trial ID
NCT04926532
Treatments Being Tested